Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/gc-biopharma-presents-updates-on-its-lsd-treatments-at-the-worldsymposium-2024-302061569.html
https://www.prnewswire.com/news-releases/european-medicines-agency-ema-grants-orphan-drug-designation-odd-to-gc-biopharmas-treatment-for-sanfilippo-syndrome-type-a-302041406.html
https://www.prnewswire.com/news-releases/gc-biopharma-announces-us-fda-approval-for-alyglo-immune-globulin-intravenous-human-stwk-10-liquid-for-adults-with-primary-humoral-immunodeficiency-pi-302017449.html
https://www.prnewswire.com/news-releases/the-worlds-first-recombinant-anthrax-vaccine-gc-biopharma-applies-for-mfds-approval-301977959.html
https://www.prnewswire.com/news-releases/fda-grants-orphan-drug-designation-to-gc-biopharmas-drug-candidate-for-thrombotic-thrombocytopenic-purpura-301949054.html
https://www.pharmaceutical-technology.com/news/gc-biopharma-cholera-vaccine/
https://www.prnewswire.com/news-releases/gc-biopharma-to-produce-cholera-vaccines-jointly-with-eubiologics-301909909.html
https://www.prnewswire.com/news-releases/us-fda-accepts-biologics-license-application-for-gc-biopharmas-gc5107b-immune-globulin-intravenous-human-10-liquid-301888979.html
https://www.prnewswire.com/news-releases/us-fda-accepts-biologics-license-application-for-gc-biopharmas-gc5107b-immune-globulin-intravenous-human-10-liquid-301888979.html